In the USA, the Food & Drug Authority (FDA) has given permission to Duke University Medical Center to offer cord blood therapy to children with neurological conditions including: Autism spectrum disorder Autism Cerebral palsy Hydrocephalus Apraxia of speech...
The American Heart Association has recently published results of a study that saw patients with heart failure receive an intravenous infusion of umbilical cord stem cells. The study comprised of 30 patients aged 18 – 75 who had stable heart failure. Participants were...
A team of scientists in Japan have demonstrated that neurons derived from stem cells can be used to treat the symptoms of Parkinson’s in monkeys. Parkinson’s affects around 1 in 500 people in the UK and is caused when dopamine-producing nerve cells degenerate and can...
In early July 2017 a panel of cancer experts unanimously endorsed CAR-T treatment for leukaemia. With FDA approval expected, it will become the first gene therapy to reach the market creating a ‘living drug’ that genetically alters a patients own cells to fight...
There are many forms of macular disease affecting eyesight, the most common of which is age-related macular degeneration (AMD). In fact, AMD is the leading cause of sight loss in the developed world. And, it is not just the old who are affected, juvenile macular...
This month saw publication of the results of a groundbreaking new trial into umbilical cord blood as a treatment for autism. The study showed enormous promise, with 75% of children showing an improvement in their condition. The medical centre responsible; Duke...
Evidence Supports Cord Blood Therapy for Cerebral Palsy
